Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Fortive
FTV
|
+$1.32B |
| 2 |
Technology Select Sector SPDR Fund
XLK
|
+$725M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$424M |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$280M |
Top Sells
| 1 |
Weyerhaeuser
WY
|
+$400M |
| 2 |
Walt Disney
DIS
|
+$234M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$214M |
| 4 |
Halliburton
HAL
|
+$207M |
| 5 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$189M |
Sector Composition
| 1 | Technology | 17.29% |
| 2 | Financials | 11.91% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.58% |
| 5 | Industrials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Home Bancorp
HBCP
$433M
| $140K | ﹤0.01% |
3,232
+2,660
| +465% | +$115K |
|
3152
iShares Core S&P Mid-Cap ETF
IJH
$101B
| $140K | ﹤0.01% |
3,475
-13,670
| -80% | -$551K |
|
3153
First Internet Bancorp
INBK
$212M
| $140K | ﹤0.01% |
4,629
+4,036
| +681% | +$122K |
|
3154
Sibanye-Stillwater
SBSW
$6.17B
| $140K | ﹤0.01% |
56,570
-73,300
| -56% | -$181K |
|
3155
TG Therapeutics
TGTX
$5.1B
| $140K | ﹤0.01% |
24,881
+15,298
| +160% | +$86.1K |
|
|
FSACW
3156
DELISTED
Federal Street Acquisition Corp. Warrant
FSACW
| $140K | ﹤0.01% |
+100,000
| New | +$140K |
|
3157
Ameresco
AMRC
$1.44B
| $138K | ﹤0.01% |
10,075
+4,636
| +85% | +$63.5K |
|
|
OPTN
3158
DELISTED
OptiNose
OPTN
| $138K | ﹤0.01% |
741
+289
| +64% | +$53.8K |
|
|
DHCP.WS.A
3159
DELISTED
Ditech Holding Corporation
DHCP.WS.A
| $138K | ﹤0.01% |
+511,337
| New | +$138K |
|
|
ATTU
3160
DELISTED
Attunity Ltd
ATTU
| $138K | ﹤0.01% |
7,300
-1,364
| -16% | -$25.8K |
|
3161
Catalyst Pharmaceutical
CPRX
$2.44B
| $137K | ﹤0.01% |
36,159
+29,093
| +412% | +$110K |
|
3162
McEwen Inc.
MUX
$748M
| $137K | ﹤0.01% |
7,089
+1,070
| +18% | +$20.7K |
|
3163
Turning Point Brands
TPB
$1.84B
| $137K | ﹤0.01% |
3,315
+2,737
| +474% | +$113K |
|
3164
New Mountain Finance
NMFC
$1.11B
| $136K | ﹤0.01% |
10,002
-5,794
| -37% | -$78.8K |
|
3165
POSCO
PKX
$15.3B
| $136K | ﹤0.01% |
2,065
| – | – |
|
3166
Sonos
SONO
$1.83B
| $136K | ﹤0.01% |
+8,505
| New | +$136K |
|
|
ZYNE
3167
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $136K | ﹤0.01% |
16,672
+1,272
| +8% | +$10.4K |
|
3168
Barings BDC
BBDC
$978M
| $135K | ﹤0.01% |
+13,472
| New | +$135K |
|
|
EBTC
3169
DELISTED
Enterprise Bancorp
EBTC
| $135K | ﹤0.01% |
3,943
+2,815
| +250% | +$96.4K |
|
|
MR
3170
DELISTED
Montage Resources Corporation Common Stock
MR
| $135K | ﹤0.01% |
7,607
+7,052
| +1,271% | +$125K |
|
3171
Digimarc
DMRC
$204M
| $134K | ﹤0.01% |
4,250
+3,430
| +418% | +$108K |
|
3172
Larimar Therapeutics
LRMR
$336M
| $134K | ﹤0.01% |
953
+812
| +576% | +$114K |
|
3173
Travelzoo
TZOO
$105M
| $134K | ﹤0.01% |
11,368
-9,631
| -46% | -$114K |
|
|
QTNT
3174
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $134K | ﹤0.01% |
443
-3,350
| -88% | -$1.01M |
|
|
AVLR
3175
DELISTED
Avalara, Inc.
AVLR
| $134K | ﹤0.01% |
3,820
+3,120
| +446% | +$109K |
|